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The deadly cervical cancer-causing human 
papillomavirus (HPV) could be eliminated 
in South Africa (SA) within 15 years if 
ground-breaking new ‘test-and-treat’ 
technology for women can be successfully 
introduced to supplement nationwide 
vaccination of primary schoolgirls.
This was said last month by Prof. Lynette 
Denny, Head of the Department of Obstetrics 
and Gynaecology at the University of 
Cape Town’s Faculty of Health Sciences 
and Principal Specialist at Groote Schuur 
Hospital. Creator of the ‘test-and-treat’ 
HPV-detecting technology, which uses the 
GeneXpert machine (currently diagnosing 
tuberculosis and rifampicin resistance), 
Denny was asked what overall impact this 
would have when added to the current HPV 
vaccination being offered at all primary 
schools. Dr Yogan Pillay, Deputy Director-
General of Strategic Health Programmes in 
the National Department of Health (NDoH), 
said that 659 330 grade 4 girls aged 9 years 
and older completed the required two doses 
of HPV vaccination at schools across the 
country in 2014/2015. The goal is eventually 
to cover all 18 000 primary schools. 
Cancer of the cervix is the most common 
cancer among women in SA, with 6 000 
new cases diagnosed annually, half of whom 
eventually die and most of whom are black. 
The vaccine cannot help the millions of 
already infected women, so the 1-hour 
‘test-and-treat’ intervention, the outcome 
of Denny’s life’s work so far, will help reduce 
this suffering via early detection and highly 
successful treatment. There are currently 250 
GeneXpert machines in the country, which 
can take cartridges from 32 analysts, one of 
which is high-risk HPV. Denny said there 
is a ‘bit more scientific work to do to make 
it slightly more accurate – we don’t want 
to waste resources as we’re already over-
treating a small proportion of women’. In 
5 years her team would be ready to ‘go with 
infrastructure for point-of-care screen and 
treat’ to prevent cervical cancer. ‘I reckon 
we’ll pick up 90% of existing disease – and 
if we can combine it with the HPV vaccine 
we’ll drastically reduce if not eliminate it 
within the next 10 - 15 years,’ she added.
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